C4U is a bio-venture company originated from The University of Osaka, established in 2018 for the practical application of the novel genome editing technology CRISPR-Cas3 technology.

CRISPR-Cas3 technology has strengths, such as its ability to induce large-scale deletions of DNA, its superior safety profile due to less concern about off-target deletion expression, and its freedom to operate (FTO) under patents.

C4U is currently conducting research and improvements to establish this technology as a genome editing platform that enables both knock-out and knock-in, and is expected to be utilised in a wide range of fields, including medicine (pharmaceuticals, diagnostics and gene therapy), biotechnology, agriculture and fisheries, and the environmental sector.

C4U Corporation

Org chart

Teams

Offices

C4U Corporation

Org chart

Teams

Offices

Related companies